[Diagnosis and prevention of toxoplasmosis].
D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000917:Antibody Formation; D000941:Antigens; D003165:Complement System Proteins; D005260:Female; D005455:Fluorescent Antibody Technique; D006386:Hemagglutination Tests; D006801:Humans; D007231:Infant, Newborn; D008297:Male; D051379:Mice; D011247:Pregnancy; D011739:Pyrimethamine / Q000627:therapeutic use; D013449:Sulfonamides / Q000627:therapeutic use; D014123:Toxoplasmosis / Q000175:diagnosis / Q000276:immunology / Q000517:prevention & control; D014125:Toxoplasmosis, Congenital / Q000276:immunology
D000900:Anti-Bacterial Agents; D000941:Antigens; D013449:Sulfonamides; D003165:Complement System Proteins; D011739:Pyrimethamine
Considerazioni sulla diagnosi e sulla profilassi della toxoplasmosi.